Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
grade C 0.99 -1.00% -0.01
OGEN closed down 1.0 percent on Wednesday, January 16, 2019, on 1.42 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical OGEN trend table...

Date Alert Name Type % Chg
Jan 16 200 DMA Resistance Bearish 0.00%
Jan 16 50 DMA Support Bullish 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Upper Bollinger Band Touch Strength 0.00%
Jan 15 50 DMA Support Bullish -1.00%
Jan 15 MACD Bullish Centerline Cross Bullish -1.00%
Jan 14 50 DMA Support Bullish 2.06%
Jan 11 200 DMA Resistance Bearish -1.00%
Jan 11 Upper Bollinger Band Touch Strength -1.00%
Jan 10 Crossed Above 20 DMA Bullish -5.71%

Older signals for OGEN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Is OGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.2
52 Week Low 0.38
Average Volume 2,444,216
200-Day Moving Average 1.0552
50-Day Moving Average 0.9546
20-Day Moving Average 0.9
10-Day Moving Average 0.9374
Average True Range 0.1046
ADX 16.2
+DI 30.904
-DI 15.4794
Chandelier Exit (Long, 3 ATRs ) 0.7962
Chandelier Exit (Short, 3 ATRs ) 1.0138
Upper Bollinger Band 1.0372
Lower Bollinger Band 0.7628
Percent B (%b) 0.83
BandWidth 30.488889
MACD Line 0.0072
MACD Signal Line -0.0116
MACD Histogram 0.0188
Fundamentals Value
Market Cap 48.77 Million
Num Shares 49.3 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -6.23
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.23
Resistance 3 (R3) 1.24 1.18 1.19
Resistance 2 (R2) 1.18 1.12 1.17 1.18
Resistance 1 (R1) 1.08 1.08 1.05 1.07 1.16
Pivot Point 1.02 1.02 1.00 1.01 1.02
Support 1 (S1) 0.92 0.96 0.89 0.91 0.82
Support 2 (S2) 0.86 0.92 0.85 0.80
Support 3 (S3) 0.76 0.86 0.79
Support 4 (S4) 0.75